If you need more lookups,
subscriptions start at $34 USD/month.
Tom King Location
Denver, CO, US
Tom King Work
Vice President of Translational R and D @ (December 2021 - Present)
Director of Research and Development @ ImmunityBio Colorado Operations (April 2020 - November 2021)
Director of Research and Development @ GlobeImmune (majority owned by ImmunityBio) (August 2017 - March 2020)
Director of Research and Development @ BioPlx Microbiomics (January 2016 - August 2017)
Director of Research and Development @ (January 2011 - May 2016)
Associate Director, Vaccine Engineering @ (January 2007 - December 2010)
Scientist III @ GlobeImmune (January 2005 - December 2006)
Scientist II @ (February 2004 - December 2004)
Biotechnology Entrepreneur @ Paragene (September 2003 - January 2004)
Senior Scientist @ (January 2002 - August 2003)
Graduate student @ Umass (January 1995 - January 2001)
Research Associate @ Schleicher and Schuell (September 1991 - August 1995)
Research Associate @ Harvard University (May 1990 - September 1991)
Tom King Education
University of Massachusetts, Amherst 1995-2001
University of New Hampshire 1986-1990
Tom King Skills
Assay Development
Drug Discovery
Biotechnology
Vaccines
Validation
Technology Transfer
FDA
Cell
Life Sciences
Immunology
Clinical Trials
Clinical Development
GMP
Molecular & Cellular Biology
Cancer
Tom King Summary
Tom King, based in Denver, CO, US, is currently a Vice President of Translational R and D at Sabin Vaccine Institute. Tom King brings experience from previous roles at ImmunityBio Colorado Operations, GlobeImmune (majority owned by ImmunityBio), BioPlx Microbiomics and GlobeImmune, Inc.. Tom King holds a 1995 - 2001 University of Massachusetts, Amherst. With a robust skill set that includes Assay Development, Drug Discovery, Biotechnology, Vaccines, Validation and more. Tom King has 2 emails on RocketReach.
Looking for a different Tom King?
Find contact details for 700 million professionals.